ARCHIVES

Letters: Kopans To Broder: Response Ignores Major Questions

This article is from The Cancer Letter archive.

Vol. 19 No. 40 | October 15, 1993

Download PDF Visit The Full Archive

Related Articles

Memorial’s Scher Warns FDA About Flaws In Provenge Data, Urges Not To Approve.

April 13, 2007

NCI, FDA Make Progress On Some Issues, Bu Differences Remain On Endpoints

November 10, 1989

Revlimid Maintenance Therapy Delayed Progression by 90%

May 27, 2011

FDA Approves Generic Oncology Injectable Currently In Shortage

September 27, 2013

Gallo, Rosenberg, Bishop, Varmus Win GM Awards

June 15, 1984

Tobacco Interests Contribute a Portion Of the $109 Million Raised by Stand Up To Cancer

September 12, 2014